DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/m7rmj2/insulin_delivery) has announced the addition of the "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" report to their offering.
The global insulin delivery devices market was valued at $8.8 billion in 2012 and is forecast to reach $13.8 billion by 2019, at a CAGR of 7%.
Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
Growth in developed economies such as the US and Europe is attributed to an increasing preference for insulin pumps and the uptake of technical advances such as artificial pancreas devices. Supply-side initiatives aim to develop artificial pancreas devices that closely mimic the pancreas by using rapid-acting insulin and multiple hormone-secreting devices for the effective control of blood glucose. The growth in developing economies is attributed to the high prevalence of diabetes and low penetration of insulin delivery devices in these countries.
Collaborations among companies and research foundations such as the Juvenile Diabetes Research Foundation (JDRF) help foster innovation in the diabetes care devices market. Many of these collaborations aim to develop artificial pancreas devices that can effectively replace the pancreas, ensuring the effective management of diabetes.
Emerging economies such as India and China are expected to grow at the fastest pace during the 2012-2019 forecast period. While developed economies will witness increasing uptake of technically advanced devices, emerging economies will continue to see increasing uptake for conventional insulin delivery devices such as insulin pens, due to their lower cost."
Key Topics Covered:
1 Tables & Figures
3 Diabetes - Disease Overview
4 Diabetes - Epidemiology
5 Global Insulin Delivery Devices Market: Device Overview
6 Global Insulin Delivery Devices Market: Market Characterization
7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts
8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts
9 Global Insulin Delivery Devices Market: Reimbursement System
10 Global Insulin Delivery Devices Market: Competitive Landscape
- Abbott Laboratories
- Antares Pharma
- Asante Solutions
- Becton, Dickinson and Company
- Bioject Medical Technologies
- Eli Lilly
- F. Hoffmann-La Roche
- Injex - Equidyne Systems
- Novo Nordisk (Subsidiary of Novo A/S)
- Owen Mumford
- Shanghai Fosun Pharmaceutical
- Tandem Diabetes Care
- Tonghua Dongbao Pharmaceutical
For more information visit http://www.researchandmarkets.com/research/m7rmj2/insulin_delivery